Viewing Study NCT04468659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-02-27 @ 6:36 AM
Study NCT ID: NCT04468659
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-01
First Post: 2020-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
Sponsor: Eisai Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Preclinical Alzheimer's Disease View
None Early Preclinical Alzheimer's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BAN2401 View
None Preclinical Alzheimer's disease View
None Elevated amyloid View
None Early preclinical Alzheimer's disease View
None Intermediate amyloid View
None A45 Trial View
None A3 Trial View
None AHEAD 3-45 View
None Lecanemab View